Global Allergy & Immunology Market Research Report 2021-2026: Extensive R&D for Immunotherapy Solutions Against Food Allergens –

Global Allergy & Immunology Market Research Report 2021-2026: Extensive R&D for Immunotherapy Solutions Against Food Allergens –

Global Allergy & Immunology Market Research Report 2021-2026: Extensive R&D for Immunotherapy Solutions Against Food Allergens –

DUBLIN–(BUSINESS WIRE)–The “Allergy & Immunology Market Research Report by Allergy Type, by Treatment Type, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19” report has been added to’s offering.

The Global Allergy & Immunology Market size was estimated at USD 2,023.65 Million in 2020 and expected to reach USD 2,250.36 Million in 2021, at a Compound Annual Growth Rate (CAGR) 11.54% to reach USD 3,897.30 Million by 2026.

In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward.

The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Allergy & Immunology Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others.

Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Allergy & Immunology Market, including

  • Adamis Pharmaceuticals Corporation
  • ALK-Abello A/S
  • Allergy Therapeutics
  • ASIT Biotech
  • Circassia
  • DBV Technologies SA
  • HAL Allergy B.V.
  • HollisterStier Allergy
  • LETIPharma
  • Merck KGaA
  • Mylan N.V.
  • Stallergenes Greer plc

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

3.1. Introduction

3.2. Market Outlook

3.3. Allergy Type Outlook

3.4. Distribution Channel Outlook

3.5. Treatment Type Outlook

3.6. Geography Outlook

3.7. Competitor Outlook

4. Market Overview

4.1. Introduction

4.2. Cumulative Impact of COVID-19

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers Growth in the prevalence of allergic disorders Strong product pipeline for novel approaches of treatments Advancements in sublingual immunotherapy formulations

5.1.2. Restraints Limitation and drawback associated with the use of allergy immunotherapy

5.1.3. Opportunities Growing awareness of allergy immunotherapies and increasing healthcare expenditure Extensive R&D for immunotherapy solutions against food allergens

5.1.4. Challenges Lack of awareness over allergy symptoms

5.2. Porters Five Forces Analysis

6. Allergy & Immunology Market, by Allergy Type

6.1. Introduction

6.2. Allergic Asthma

6.3. Allergic Rhinitis

6.4. Food Allergy

6.5. Pet Allergy

7. Allergy & Immunology Market, by Distribution Channel

7.1. Introduction

7.2. Hospital Pharmacy

7.3. Online Pharmacy

7.4. Retail Pharmacy

8. Allergy & Immunology Market, by Treatment Type

8.1. Introduction

8.2. Subcutaneous Immunotherapy (SCIT)

8.3. Sublingual Immunotherapy (SLIT)

9. Americas Allergy & Immunology Market

10. Asia-Pacific Allergy & Immunology Market

11. Europe, Middle East & Africa Allergy & Immunology Market

12. Competitive Landscape

12.1. FPNV Positioning Matrix

12.1.1. Quadrants

12.1.2. Business Strategy

12.1.3. Product Satisfaction

12.2. Market Ranking Analysis

12.3. Market Share Analysis, By Key Player

12.4. Competitive Scenario

12.4.1. Merger & Acquisition

12.4.2. Agreement, Collaboration, & Partnership

12.4.3. New Product Launch & Enhancement

12.4.4. Investment & Funding

12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles

For more information about this report visit


Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900